The stem bark of Ampelocera edentula Kuhlm. (Ulmaceae) is used by the Chimanes Indians from Bolivia for the treatment of cutaneous leishmaniasis caused by the protozoan Leishmania braziliensis. A chloroform extract of the stem barks was found to be active against extracellular forms of Leishmania ssp. and Trypanosoma cruzi at 50 ,ug/ml. Bioassay-guided fractionation of this extract allowed us to isolate one active compound. Its structure was elucidated by spectral and chemical studies as 4-hydroxy-1-tetralone. BALB/c mice infected with L. amazonensis (PH8) or L. venezuelensis were treated one day after the parasitic infection with 4-hydroxy-1-tetralone (25 mg / kg/day) or with reference drug, GlucantimeO (56 mg Sb"/kg/day) for 14 days. Lesion development was the criteria used to evaluate the disease severity. 4-Hydroxy-1-tetralone was slightly less effective than the reference drug against L. amazonensis or L. venezuelensis. Single treatment near the site of infection, 14 days after infection with L. amazonensis, with 4-hydroxy-1-tetralone (50 mg/kg) was more effective than Glucantime (112mg/kg). This study is, to our knowledge, the first to show the activity of a tetralone for the experimental treatment of New World cutaneous leishmaniasis.
Introduction
Cutaneous and mucocutaneous leishmaniasis are protozoan diseases of the tropic and subtropic areas in South America, particularly in the subandean areas of the humid lowlands of Bolivia. In the endemic regions of Bolivia, the classic treatments are too expensive or unavailable for the population suffering from cutaneous leishmaniasis or espundia. In Bolivia, the Instituto Boliviano de Biologia de Altura (IBBA) and the French Institute of Scientific Research for the Development in Cooperation (ORSTOM) have initiated an original program of investigations on alternative compounds for the treatment of cutaneous leishmaniasis. We have collected and studied medicinal plants used by Chimane Indians as a specific treatment for the cutaneous leishmaniasis. In previous works, we have described the chemical and biological studies of two antileishmanial Chimane-plants, Pera benensis Rusby (Euphorbiaceae) (1) and Galipea longifora Krause (Rutaceae) (2). The aim of this study is to evaluate the leishmanicidal activity of another plant identified as Ampelocera edentula Kuhlm. (Ulmaceae).
The stem bark in the form of a poultice is applied on the cutaneous lesions until complete cicatrization of the wound. In a preliminary screening, a chloroform acid extract of the stem barks of A. edentula displayed an in vitro activity at 50 pg/ml against five strains of promastigote forms of Leishmania species and five strains of epimastigote forms of Trypanosoma cruzi. Activitydirected fractionation and purification of this crude extract of the stem barks afforded one active compound identified by its physical and spectral data as 4-hydroxy-1-tetralone (1). This work is devoted to the in vitro antileishmanial and trypanocidal activities and the in vitro activity of this tetralone. We sought to verify its effect when administered directly in the rear footpad of mice infected with L. amazonensis.
4ctivity of a Tetralone Isolatedfrom Ampelocera edentula

Materials and Methods
Isolation and chemistry
General experimental procedures
The UV spectrum was recorded on a Unicam SP 1800 spectrophotometer; IR spectrum was measured in KBr with a Perkin Elmer 257 spectrophotometer, 'H and I3C-NMR spectra were recorded in CDC13 (6 ppm) on a Bruker AC 200 P spectrometer operating at 200 and 50 MHz, respectively. The EImass spectrum was obtained at 70 eV on a Nermag R 1010 C mass spectrometer. Silica gel GFZ54 (Alufolien 60 F 254 Merck 5554) and silica gel 60 H (Merck 7736) were used for TLC and CC, respectively.
Plant material
Stem bark of Ainpelocera edentula Kuhlm. was collected hy A. Fournet (A. F. 884) 
Extraction and isolation
Stem barks (3 kg) of A. edentula were acidified with 0.5 N HC1 and extracted with chloroform. The crude extract (58g) was chromatographed on silica gel H (1.5kg) and eluted with a CHCl,-MeOH gradient. The active fraction (7.9 g) eluted with CHCl,-MeOH, 99/1, was further purified on silica gel H (240 g), followed by a column chromatography on Sephadex LH 20, using CHC13, MeOH, 7/3, as eluent. The active compound (0.87 g) was identified by its physical and spectral data as 4-liydroxy-ltetralone (1).
Spectral data for 4-hydroxy-1-tetralone Culture and maintenance of the promastigote forms ofLeishmaizia ssp. and the spimastigote forms of Trypanosoma cruzi
Cultures of the extracellular forms ofLeishmania ssp. and Trypanosoma cruzi were prepared and maintained as described previously (3, 4).
In uivo studies
Mice: Female and male BALB/c mice were supplied by the Charles Rivers Breeding Laboratory and were then bred in IBBA (Bolivia). Mice weighed between 18-20 g and were eight weeks old when experiments were initiated.
Parasites: The mouse footpad infection has been used as model for these experiments (5,6).
Leishmania amazonensis MHOM/IFLA/BR/67/ PH8 and L. uenezuelensis MHOM/VE/74/PM-H3 were used. The source and history of these isolates have been previously described (7). All strains were maintained by passage every 6 to 8 weeks in hamsters. BALB/c mice (n = 6) were infected subcutaneously in the right rear footpad with 1 X lo6 amastigotes obtained from donor hamsters. The parasites were delivered in 200 pl phosphate buffered saline (PBS). Drug treatment N-Metliylglucamine antimonate (GlucantimeB) with a pentavalent antimony (Sb") content of 28 % by weight was purchased from the Rhône-Poulenc, France and was used as reference drug. Two experiments were conducted. Mice in the first experiment were treated by the subcutaneous route. Glucantime@ was given at a dose of 56mg Sb"/kg daily and 4-hydroxy-ltetralone at 25 mg/kg daily. This tetralone was dissolved in 40 pl of polysorbate (Tween 80, Prolabo) and GlucantimeB in PBS. Untreated mice received PBS and Tween 80. Drug treatment commenced one day after the inoculation of amastigotes and was continued once daily for 14 days.
In a second set of experiments, mice were treated directly on the infected rear footpad with a single treatment 14 days after the inoculation of parasites. In these experiments, mice were treated with Glucantimea at 112mg Sb'/kg and with 4-hydroxy-1-tetralone at 50 mg/kg.
Results
In vitro effects on Leishmania ssp. and Trypanosoma cruzi
After 48h incubation with 4-hydroxy-ltetralone, the ICgo for five strains of promastigote forms of Leishmania was 10 pg/ml. For an easy comparison, results obtained in the presence of 4-hydroxy-l-tetralone, pentamidine, and meglumine antimonate are presented together in Table 1 . 4-Hydroxy-1-tetralone was tested in vitro on five strains of epimastigote forms of Trypanosoma cruzi. The effects of this compound, nifurtimox, and benznidazole on the growth of T. cruzi are presented in Table 2 . After 48 h, 4-hydroxy-1-tetralone showed an inhibitory activity on all strains, the ICgo was 10 pg/ml. Nifu-timox and benznidazole did not show any inhibitory activity against multiplication of epimastigote forms of Trypanosoma cruzi below 25 pg/ml. Treatments for 14 days in mice infected with L. amazonensis (PEI81
The activity of 4-hydroxy-1-tetralone against experimental cutaneous leishmaniasis caused by Leishmania amazonensis in BALB/c mice is presented in Fig. 1 . The mice treated with 4-hydroxy-1-tetralone and Glucantime developed similar lesion size after four weeks, 1.1" and l m m , respectively. We have observed an identical increase in the development of the lesion size in mice treated with 25 mg/kg of 4-hydroxy-1-tetralone daily or with 56mg Sb"/kg of GIucantime daily, respectively, 1.2" and 1". Ëight weeks after infection, mice treated with 4-hydroxy-1-tetralone had an average lesion size of 3.86 mm, this size was 3.28 mmin mice treated with the reference drug and 4.95 mm in the untreated mice. Preliminary toxicological eyaluations of 4-hydroxy-1 -tetralone administered in BALB/c mice indicated that this drug had a therapeutic index with an acute intraperitoneal 50 % lethal dose of 168mg/kg. No apparent signs of drug toxicity, weight loss or hair loss, were observed in the experiments but an inflammatory effect was seen near the site of administration of drug.
Treatments against L. venezuelensis
The results obtained with this model are presented in Fig.2 . Four weeks after infection, mice treated with 4-hydroxy-1-tetralone or with the antimonial compound had an average lesion size of 1.28" and 0.95mm, respectively, compared with 2.06" in untreated mice. During the last four weeks of the experiment, we observed that the sizes of lesions were similar in mice treated with 4-hydroxy-1-tetralone or reference drug, 3.77" and 3.3mm, respectively. After eight weeks of experiment, the progression of the Leishmania uenezuelensis infection was slower in mice treated with reference drug than in mice treated with 4-hydroxy-1-tetralone (respectively, 4.25 mm and 5.05 mm).
Single treatments on the footpad in mice infected with Leishmania amazonensis
PH8)
In this experiment, the treatment with 4-hydroxy-1-tetralone was administered at the site of parasitic infection, 14 days after infection with Leishmania amazonensis (PH8). The results obtained are shown in Fig. 3 . We have observed a severe inflammatory effect in mice treated with 4-hydroxy-1-tetralone at 50 mg/kg. This inflammation was resorbed three weeks after the local treatment. Single treatment with 4-hydroxy-1 -tetralone (at 50 mg/kg) reduced the severity of lesions in this model and appeared more effective than pentavalent antimony. Eight weeks after infection, mice treated with 4-hydroxy-ltetralone had an average lesion size of 2.55 mm, compared to 2.85 mm in mice treated with Glucantime and 4.90" in untreated mice. 
4-hYdroxY-l-tebalone
Discussion
The bioassay guided fractionation of Ampelocera edentula led to one active compound identified as the known product, 4-hydroxy-1-tetralone or 4-hydroxy-3,4-dihydro-2H-naphthalenone. This product is considered as a metabolite from the degradation of naphthalene and l-napthol(8,9) and as an intermediate in the biosynthesis of 1,4-naphthoq~1inones (8). It was previously encountered in fungi (10) and yeasts (11). It is also used as an intermediate in the synthesis of antibiotics (12). To our knowledge, this tetralone has been isolated here for the first time from higher plants.
The evaluation of the in uivo antileishmanial activity of 4-hydroxy-1 -tetralone showed the efficacy of this compound. Results of the in uivo experiments indicated that all mice treated with 25mg of 4-hydroxy-1-tetralone per kg daily for 14 days developed a similar lesion size when compared with mice treated with the antimony drug. We observed that 4-hydroxy-ltetralone, administered at 50mg/kg near the site of parasitic infection in Leishmania amazonensis infected mice, is more effective than the antimony reference drug at 112 mg/Sb"/kg. These results demonstrate that the traditional use of Ampelocera edentula in endemic areas of cutaneous leishmaniasis together with our clinical observations give excellent proof of the efficiency of 4-hydroxy-1 -tetralone. This class of compounds was previously described as antiprotozoal products (13-161. These compounds generate free oxygen radicals within parasites which lack protective mechanisms against such radicals (17), particularly catalase (18). They are described as cytotoxic, carcinogenic, and mutagenic for laboratory animals (19, 20) . Some authors reported schistosomicidal activities of tetralones (21).
This study confrms that the poultices of stem bark of Ampelocera edentula, as used by Chimane Indians, are effective against cutaneous leishmaniasis. This work describes the first example of activity of a tetralone against Leishmania species, but the use of 4-hydroxy-1 -tetralone as antileishmanial drug is critical because of its high cytotoxicity. Studies of derived 4--hydroxy-1-tetralone compounds are in progress in our laboratory for the treatment of cutaneous and visceral €eishmaniasis.
